COMPANY

InterveXion Therapeutics, LLC

HQ: Little Rock, AR source

From public records: InterveXion Therapeutics is a Little Rock, AR company developing IXT-m200, an anti-methamphetamine monoclonal antibody, with NIH (NIDA) support; its most recent NIH award on record is from July 2024. source · 2024-07-23

Location: Little Rock, AR · source · Oct 15, 2026

Profile checked Oct 10, 2026